Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shorts. best to get on the NowthWest Bio train before it leave the station, or at lease cover up.
Holding from News release from NorthWest Bio.
DCVax-L FDA approval for the treatment of Brain Cancer.Next.
NorthlWest DCVax-L for the treatment of Brain Cancer news could be release of Phase III FDA pass trial study. Next FDA approval of DCVax-L.
Conference in London on September 21 thru the 22 Sponsor by NorthWest Bio. Expect positive results on DCVax-L treatment for Brain Cancer.
Lets stick to what we can and had find on the internet and thru press releases. NorthWest Biotherapitics (NWBO) is sponsoring a conference in London the day after tomorrow September 21 thru 22. Informational data on the company's website report for DCVax-L is very promising for the treatment of brain cancer. It shows and stated that a large percentage of the patients giving DCVax-L many has live pass 6 years, and other patients from the first trial study thru the third trial phase states that some is still surviving pass 10 years, and is living productive lives, when the life expectancy for patient diagnose with brain cancer is 8.9 months to 14.9 months.
I believe in the reports and data that is documented on NorthWest Biotherapeutics, Inc Website. By researching the data NorthWest Bio is going to have a very positive conference in London. Shareholders imo will be updated on at lease 1 or all of the company's progress involving the trial studies, before the conference in London. I believe NorthWest Bio will give the shareholders an update on DCVax-L progress, before the London conference.
In London time that is less then 2 days away. According to the SEC rules information must be made public if it is to be release.
Next week we shall all learn the progress of the clinical trials and how well the treatments are helping the patients in the continuing trial studies using DCVax-L for the treatment for brain cancer. Also maybe we will get updates on the other trial studies and patients. My hope is for all the patient to benefiting from these trial studies and get well soon.
Okay, according to you and a another, he said "good news gets twisted into bad news on a regular basis by some people". I must admit, I do like the part "good news". Maybe I should have read it twice.
Agee. Big pharma want to buy these types of little immune drug development bio tech companies. So that they can put the curable or better treatment drug on the back burner. Big pharma will have no intention of ever bring the immune develop drug to the markets. So that patient will always be in need of their non curable drugs like for instance cancer and diabetes.
you know there are a lots of big hedge funds who try their best to drive a small Bio company out of business so they and others can cease their products very cheap in an liquidation of their assets. They've been hitting NorthWest very hard every since they are coming closer and closer to a cure or a better treatment for brain cancer. You know how bad this will hurt big pharma if a bio company was to come up with a cure or a better treatment for cancer. It would make all of the other cancer drug obsolete (discontinue).
It seem as others are putting stumbling blocks in NorthWest way, cause the company to delay studies, blocking a better revenue to raise funds for research and studies, and bogus claims against the company. This could be some of the reasons The company keep seeking funds by selling cheap warrants to investors and others to raise funds to complete and continue its trial studies. Many big pharma will do almost Anything to keep this company for bringing a cure or a better treatment for brain cancer into the markets. Remember big pharma do not want a cure for cancer, diabetes, Alzheimer, hypertension and so on. These are big money making illness to treat.
While doing research on Northwest Bio, I read there was 2 patient who was diagnose with brain cancer who are participating in Northwest Bio DCvac-L studies for brain cancer. They have been in the studies from the first trial study giving DCvax-L all the way thru trial study phase III. That has been 10 years up to 2015. I wonder will the Northwest Bio topic be about the 2 brain cancer survives at the conference in London this September and New York. I believe those 2 brain cancer patients is still surviving, and that might be the big News, and one of the reasons for why the company is staying quiet. Another reason to add to the other reasons why the company is so quiet. We will know next week. They will be excepting questions. It's a Q&A Event also.
Please don't talk about a buyout that gives me goose bumps. Just thinking about the reason Northwest is so quiet is because they might be in talks of a buyout if their phase III cancer drug is going to get approval or some big pharma want it before everyone else big pharma get their hands on Northwest DCvax-L brain cancer drug. Who knows what Northwest Bio is up to or planning. One way or the other we will find out. Come on News the bulls are waiting for you.
That surprising Navidea PR should had added more icing to the cake. Very nice surprise.
Wow!! When we break thru their resistance its a go. It's us against them. Let's stampede thru some shorts and conversions. Let's Go NorthWest.
Seem like they broke thru the first force field, and I hope they used everything they had, so we can break thru their resistance.
Those got to be institutional conversion shares being dump so cheap.
IMO You can make some, most, or all of your money back. I would buy more when the price is ridiculous low, and trade my way back up until I get all of my money back. You guys who are long term investors or shareholders are part owners of NorthWest Biotherapeutics, you don't have to sit and wait for Linda Power to let you know what is going on. Call the company, not the investors relation number. Call the company directly, when you're not getting the answers to satisfy your concerns from investors relation about your investment or the company progress. Better yet make an appointment and go in and express your concerns. You have that right. Not just one person, but as many of you who can.
Don't just invest a lot of money into a company and just sit around and watch it fall, by leaving everything into the CEO and other top management hands. Investors relation most of the time just pass investors and shareholders off, mainly shareholders. Don't believe that junk there are channels to go thru. That is a lot of bull when the management is losing your money and running the company into the ground get more directly involve. Hell I have Just $5k invested here, I know that is probably not much compare to many invested with NWBO, but let my money start fall, because of management not doing their job. I demand updates on progress of the company and it products in development at lease twice a year if not monthly.
And this is not an opinion.
Guys stop worrying, we're going to get positive news from NWBO. News can be release at any giving moment. We don't know exactly when, but we do expect it will be release. We just got some surprising news on my board. We wasn't expecting the news we received today, but we got positive news and the stock is soaring. The same is going to happen for NWBO. Other wise I won't be here. IMO when Northwest Bio release the news whether it is about phase III brain cancer study or Phase I and phase II study, which ever comes first, the stock imo is going to soar.
I do believe Northwest will be releasing a positive report on one of its trial studies, today or before the 22 of September.
NEWS OUT !!
My portfolio is looking real good in a down market, especially the cash in it. Thanks for dropping that hint about your other pick. I have bank on it, and holding from 40. I'm expecting to bank on it and NAVB. Those 2 is going to make me a big fortune very soon.
Yes, the running of the bulls stampede over the bears. I can't wait for next week for this to happen.
I agree with you 100% Clay, it is time for the bulls to step back up. Let's Go NorthWest Bio.
Compare to the shares that has been traded by converted warrant holders, day traders, shorts covering, a few scare hands and investors such as myself whom brought in at .40 for 8K shares today hoping to make a nice profit between now and September 21 to 23. What I'am trying to say is when you total up the number of shares traded between Monday and today they total less than 50 million shares. Today wasn't a big selloff less than 6.4 million traded today and half of those trades was not sell off, but imo warrant conversion holders dumping, flippers flipping, and Shorts covering, and peeps like myself buying for short turn investment, bank on Good news next week.
I'am here to say the situation is not bad as some might think. It was not a big selloff today imo those was mostly conversion shares hitting the market and that was not that many, and a few scare hands along with flippers, and a few shorts. About 1/4 of the shares sold this morning brought the price down to .3802. That is about 1.6 million shares. and 1/3 of them was buys at the ask. NWBO average trade today was around .417 less than 4 million trades total. Out of a 155 million out standing shares over 100 million was holding. Maybe even more. Some of those 6.4 million shares today was traded back and forward, but not many.
Everyone needs to sit back and understand market trading, or at lease your IPO trading for your company or investment company. It was not as bad as far as trading shares, but bad if the long terms mostly sit back and let less then %4 drive down their pps from .52 to .3802 and close at 4201. Now that is pitiful.
Yes it is Undervalue. CRG caused the pps to drop earlier in the year when they imo, wrongfully try to re-call the loan, because of board members. NAVB was current on their loan, and has never been late or missed a payment. Once the deal in progress between Navidea and Cardinal Health is finalized and signed the pps will return and even go much higher. Please forgive the grammar.
That what shorts hope, but it not going to happen. Don't believe me just watch. The research is there. The name for the presenter I mention is incorrect. Most of the other research material is on the web. In at 40 holding for next week.
I did research on DCvax-L trial for Glioblastoma Multiforme (GBM) Brain Cancer. Phase III trial study is expecting to have positive encouraging results of its continuing study using DCvax-L to treat patients who are diagnose with brain cancers. The results is some of the patients has live beyond 11 years since being treated with DCvax-L, and many more are living pass 6 years when the life expectancy for patient with brain cancer is 8.6 months. and a total of 14.9 months when treated with chemo. This is very good encouraging news for patients diagnose with brain cancer and the medical field. Patients treated with DCvax-L for brain cancer can live longer lives then they could in the pass.
Dr Linda Liau to present those findings in a conference in London on September 21 and 22. The market might get these results before the London Conference, because of SEC rulings of info must be made public so every one has a fair chance of knowledge about a stock new info. This is the type of news the markets and medical field has been waiting for.
DCvax-L results will help to send Northwest biotherapeutics(NWBO) IPO soaring. Great Job Northwest Biotherapeutics and investors.
I research and find out you guys are expecting some major "BIG" news, which could drop at any moment. I think you might have something there. Thanks for sharing your list of info.
Sorry amikik, I'am late in answering your question. I'am just getting back to my home office. Anyway to answer your question, do I believe Navidea will reach new highs. I won't pretend to know everything, but Yes, I do believe Navidea will reach new highs, when the deal is signed between Navidea and Cardinal Health, which would payoff CRG, and add a nice "cash flow" on the balance sheet. Plus the $310 million cap will add continually quarterly funds and revenue for Navidea. The company has a very good pipeline of rebust assets they're working on, which is the Rheumatoid Arthritis and the Cardiovascular disease diagnostic products.
I believe the Rheumatoid Arthritis diagnostic drug and the Cardiovascular disease diagnostic drug is going to be a success after all the trial studies is completed. This is where the big money is going to start rolling in. Don't forget Navidea will still be selling it Lymphoseek diagnostic drug to Europe, South America, Asia, and so on. The company will be able to sell it product Lymphoseek everywhere it has a market except for North America. The continuing sale of Lymphoseek will also bring in more revenue for Navidea along with the royalties it will be receiving for Cardinal Health for years to come.
Otherwise I would not be here if I did not do my research very well on Navidea. This company is worth my investment, because I know what I own. I see the big picture of Navidea of where it is going. Plus I still believe Navidea have all the signs for a near future buyout, but that just my opinion.
Now don't you wish you would have kept that statement to yourself of Navidea going down to .75 cent. Yesterday someone mention it going down as low as .65 cent. We all known who that were.but still I'am glad to have you back here instead over there at NwBo in Cincinnati.
Good Luck to you, and stick with the winning team.
Yes, you did. I had that feeling yesterday, that we would get good news today from Navidea.
You have not seen nothing yet. Just wait until Navidea and Cardinal Health deal is signed. IMO Navidea will never be under a dollar again.
The best is yet to come!! Let's Go NAVB.
Thank You. I'am holding out for the sweet deal between Navidea and Cardinal Health. Navidea will have a clean slate after it pay off CRG and a very nice cash flow. Plus a $310 million dollar cap, which will keep funds flowing into Navidea for years.The funds at closing and the quartly cash flow from Cardinal Health will help to grow Navidea bigger than it was before the deal. Navidea will have a great balance sheet after this deal is signed.
GLTY.
LOL !! I agree with you 100%. Plus there is much more to come. Good Things is happening for Navidea Biopharmaceuticals, inc.
Thank God for it all.
Thank God, Good News is out. Navidea is going to get its deal with Cardinal Health inc. Plus the US Patenting Office giving the patent for the "Cold Kit". Patent$ 9439985.
Let's Go NAVB !!
yes, especially with the good news of the patent for the "COLD KIT". The PR show Navidea has 2 Conference Presentations, one is on the 22 of September, and the other is on 27 of September. The Conferences Presentations will be held in Las Vegas and New York. The Presentations is passed September the 21st. I guess everything went well getting the courts to approval more time for Cardinal Health and Navidea to close the Lymphoseek deal in progress. This is very Good News.
I saw it on the United States Patent Office Website. It is Patent# 9439985 Dated September 13, 2016 patft.uspto.gov/netacgi/nph-Parser
Stock1, if you can not get connected to the United States Patent Office Website by using the web address I have type above.try going to the United States Patent Office Website, Original site, next search for look-up patent or type in Patent$ 9439985. It is there.
MORE NEWS. Navidea
EU has received it's Patent for the "COLD KIT".
[b]patft.uspto.gov/netacgi/nph
NEWS OUT.
Agree, the $80 million upfront funds at closing will clean up Navidea balance sheet, and add a very nice "Cash Flow". The best thing about the $80 million and $310 million cap it is not a loan or warrants units to dump into the market that dilutes shareholders value. The Funds is pure "CASH" for the sale of Lymphoseek in the North America regions to Cardinal Health. This deal will go thru. Plus Navidea can continue to sale its Lymphoseek product to the rest of the world out side of the North America Markets.
Navidea will still have a product to sell.
All sectors in the US markets was in red. Navidea did very well to had held its ground in the 80's in a very bad volatile market. Yes it was in the red also, but not before it went green and stayed there for a while. Navidea stayed in the mid 80's most of Tuesday. It close at .826 during regular business hours, and I see where it closed at .89 during after hours. I say compared to the rest of the market NAVB did good today, it did not crash like a few had hope.
Good Job everybody.